Catalyst Event
Akeso Inc (9926) · Earnings Release
From Akros SCHK HK-Korea Cosmetics Index (ASHKCOS)
3/26/2026, 12:00:00 AM
Akeso announced its full-year 2025 financial results on March 26, 2026. Revenue grew 43.9% year-over-year to RMB 3.06 billion, but the net loss widened to RMB 1.11 billion, missing analyst expectations. High importance estimated due to potential for >10% price impact from significant earnings miss, expected.
Korean Translation
2026년 3월 26일 2025년 연간 실적 발표. 매출은 전년 대비 43.9% 증가한 30억 6천만 위안을 기록했으나, 순손실은 11억 1천만 위안으로 확대되어 분석가 예상치를 하회함. 실적 하회에 따른 10% 이상의 주가 영향이 예상되어 High 등급으로 분류함. 예상됨.
Related Recent Events
CSPC Pharmaceutical Group Ltd (1093) · Other
Final dividend of HKD 0.15 per share for FY2025 (total HKD 0.29, +11.5% YoY) with ex-dividend date June 24, 2026; low importance as dividend increases typically result in minor positive price adjustments scheduled.
6/24/2026, 12:00:00 AM
Samsung Biologics Co Ltd (207940) · Earnings Release
Q1 2026 earnings release for April 29, 2026 scheduled. Minimal market impact from the date announcement expected.
4/29/2026, 12:00:00 AM
HLB Co Ltd (028300) · Other
An investor relations (IR) meeting to announce the group's integrated strategy and the progress of major pipelines; low impact anticipated as it is a routine communication event, scheduled.
4/9/2026, 12:00:00 AM
Celltrion Inc (068270) · Other
Cancellation of 9.11 million treasury shares, valued at approximately KRW 1.71 trillion, effective April 1, 2026. This largest-ever cancellation is expected to have a high market impact.
4/1/2026, 12:00:00 AM
Samchundang Pharm Co Ltd (000250) · Other
The 82nd Annual General Meeting of Shareholders on 2026-03-30 is a routine meeting with low expected price impact scheduled.
3/30/2026, 12:00:00 AM
Hanwha Corp (000880) · Other
The ex-dividend date for the 2025 final dividend of 1,100 KRW per common share is scheduled for 2026-03-30; market impact is estimated to be low (>=1%) following typical dividend adjustments, scheduled.
3/30/2026, 12:00:00 AM